NCT05340634 - Evaluation of Metionac for the Modulation of Metabolic and Endocrine Parameters in Patients With PCOS. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 20, 2020

Primary Completion Date

February 2, 2022

Study Completion Date

February 2, 2022

Conditions

Polycystic Ovary Syndrome

Interventions

DIETARY_SUPPLEMENT

Metionac

Metionac is a food suplement composed by 200 mg of SAMe, 100 mg of NAC, 75 mg of ALA and 0,65 mg of vitamin B6 per tablet for 6 months

DRUG

Oral contraceptive

Drospirenone 4 mg once a day

Trial Locations (1)

Hospital Quironsalud San José, Madrid